Joseph Wu
Oprichter bij Greenstone Biosciences, Inc.
Profiel
Joseph Wu is the founder of Greenstone Biosciences, Inc. which was founded in 2022.
He is currently the Director at Stanford University School of Medicine since 2013 and an Advisor at Bioverge Funds Management LLC.
Dr. Wu completed his undergraduate degree from Yale School of Medicine in 1997 and his graduate degree from the University of California, Los Angeles in 2004.
Actieve functies van Joseph Wu
| Bedrijven | Functie | Begin |
|---|---|---|
Greenstone Biosciences, Inc.
 Greenstone Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Greenstone Biosciences, Inc. is a biotechnology company that specializes in clinical genomics, iPSC technology, AI/ML, and drug development. The company is based in Palo Alto, CA. Greenstone has extensive knowledge and expertise in generating patient-derived human iPSCs and differentiating them into numerous cell types for disease modeling and drug discovery. The company was founded in 2021 by Joseph C. Wu, PhD and Jade Chao, MPH. | Oprichter | 01-01-2022 |
| Stanford University School of Medicine | Directeur/Bestuurslid | 01-06-2013 |
Bioverge Funds Management LLC
 Bioverge Funds Management LLC Investment ManagersFinance Bioverge Funds Management LLC (Bioverge Funds Management) is a venture capital subsidiary of Bioverge, Inc. founded in 2016 by Neil Jay Littman and Rick Gibb. The firm is headquartered in San Francisco, CA. | Consultant / Adviseur | - |
Opleiding van Joseph Wu
| University of California, Los Angeles | Graduate Degree |
| Yale School of Medicine | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Greenstone Biosciences, Inc.
Greenstone Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Greenstone Biosciences, Inc. is a biotechnology company that specializes in clinical genomics, iPSC technology, AI/ML, and drug development. The company is based in Palo Alto, CA. Greenstone has extensive knowledge and expertise in generating patient-derived human iPSCs and differentiating them into numerous cell types for disease modeling and drug discovery. The company was founded in 2021 by Joseph C. Wu, PhD and Jade Chao, MPH. | Commercial Services |
Bioverge Funds Management LLC
Bioverge Funds Management LLC Investment ManagersFinance Bioverge Funds Management LLC (Bioverge Funds Management) is a venture capital subsidiary of Bioverge, Inc. founded in 2016 by Neil Jay Littman and Rick Gibb. The firm is headquartered in San Francisco, CA. | Finance |
